An epidemiological study was carried out to compare the prevalence of facial flushing in non-diabetics, patients with insulin dependent diabetes, and patients with non-insulin dependent diabetes in response to 40 ml sherry taken 12 hours after 250 mg chlorpropamide or placebo, administered double blind in randomised order. A flush after chlorpropamide but not placebo was reported by 6-2% of non-diabetics (17/273), 9 7% of insulin-dependent diabetics (14/145), and 10 5% of noninsulin dependent diabetics (25/239), excluding those receiving long term chlorpropamide treatment. The differences were not significant. This response was unrelated to age, sex, body mass index, and family history of diabetes in all three groups. Patients taking long term chlorpropamide, however, showed a significantly (p <0 01) higher prevalence of flushing after both chlorpropamide and placebo (56 3%; 9/16) compared with the rest of the non-insulin dependent diabetics (16.7%; 40/239), the insulin dependent diabetics (6-9%; 10/145), and the non-diabetics (5 9%; 16/273). Patients receiving long term chlorpropamide would be expected to flush with sherry after a placebo tablet because of therapeutic plasma concentrations of the drug.
Introduction
In the late 1950s several reports drew attention to the intense facial flush experienced by patients treated with chlorpropamide when they drank even small amounts of alcohol.1-5 The term chlorpropamide alcohol flush was later coined by Leslie and Pyke6 to denote this particular response, which is distinct from the flush resulting from sensitivity to alcohol alone, seen commonly in Chinese and other Mongoloid peoples.7 Chlorpropamide alcohol flushing was reported in 10-35% of patients treated with chlorpropamide,1-5 but, as pointed out by Fitzgerald et al,9 many diabetics abstain from alcohol and others may not report the reaction. They found that of 100 patients taking chlorpropamide, 33 did not drink alcohol and 22 of the remainder had experienced facial flushing after alcohol.
After observing chlorpropamide alcohol flushing in a diabetic woman and her two diabetic daughters Leslie and Pyke investigated a possible genetic link between the response and diabetes, by using a standard "single challenge" test. 6 A single preparatory 250 mg dose of chlorpropamide or a placebo tablet was followed 12 hours later by 40 ml sherry. The response was considered to be positive if the subject complained of, or admitted to, a sensation of facial flush only after the chlorpropamide preparation. Positive responses occurred in 51% of 234 patients with non-insulin dependent diabetes mellitus (81% of those with a family history of diabetes) compared with only 1000/ of 60 patients with insulin dependent diabetes mellitus and 10% of 60 non-diabetic controls.6 These findings and the results of studies of families and twins6 10 led them to propose that the chlorpropamide alcohol flush may represent a genetic marker for a common subtype of non-insulin dependent diabetes with strong familial occurrence.
We report an epidemiologically based study in which we compared the prevalence of chlorpropamide alcohol flushing in populations of patients with non-insulin dependent diabetes, patients with insulin dependent diabetes, and non-diabetic volunteers.
Subjects and methods
We randomly selected 800 patients with insulin dependent or noninsulin dependent diabetes and 800 non-diabetic subjects and asked them to participate in the study. Diabetics-Over one year the clinical notes of all patients aged routinely attending the diabetic clinics of Greenwich and Lewisham district general hospitals were systematically examined. Every week two patients were randomly selected from each decade of age and either sex to a total of 800. The details of the study were fully explained to each participant and written consent requested. The study was approved by the ethical committees of the hospitals concerned. The patients were classified as insulin dependent or noninsulin dependent1' according to the following rules. (1) All diabetics not receiving insulin injections were classed as having non-insulin dependent diabetes. (2) For those patients injecting insulin a history of unbroken insulin treatment from the time of diagnosis (excepting short breaks of up to a month) was accepted as indicating insulin dependent diabetes. (3) All other patients receiving insulin were classed as having non-insulin dependent diabetes unless insulin had been started during an episode of severe ketosis and continued subsequently, in which case they were classed as having insulin dependent diabetes. These three rules could not be applied in four cases, and these patients were excluded.
Non-diabetics-Control subjects were recruited from the staff of the Greater London Council after approval for the study by their medical and staff associations and explanation in their house journal. Eight hundred employees were randomly selected to provide 100 subjects of each sex in each decade of age group between 20 and 59 years. Known diabetics were excluded. Due to selective retirement Insulin dependent diabetics 1-0
subjects aged over 60 were not included in the study. Each selected employee was requested by letter to give voluntary consent to take part; a single reminder was sent if no answer was received.
Test procedure-The chlorpropamide alcohol flush response was assessed using the single challenge test with placebo control as described by Leslie and Pyke6 but administered double blind and in randomised order. Each subject was instructed to take with breakfast a 250 mg chlorpropamide or placebo tablet one week apart followed by 40 ml sherry 12 hours later. Regular drugs were continued, but casual analgesics were forbidden for 48 hours before each test.
Patients taking regular aspirin, indomethacin, or other non-steroidal anti-inflammatory drugs were excluded from the study since these drugs may block the flush response.12 13 All participants were asked to complete a standard test questionnaire inquiring whether they had experienced any of several diverse specified symptoms, one of which was flushing of the face, during the hour after each of the two sherry age and sex. Only one test (either with chlorpropamide or placebo) was carried out by 7 8 %, 10 8 %, and 10 0% of the groups respectively, the remainder not completing either test despite having given consent. Hypoglycaemic treatment in patients with non-insulin dependent diabetes who completed the tests consisted of diet alone or with metformin (84 patients), glibenclamide alone or with metformin (96), insulin (47), chlorpropamide (16) , and other drugs (12). The results for patients taking chlorpropamide therapeutically are presented separately from those for the rest of the group with noninsulin dependent diabetes because when the data were analysed these patients were found to have responded differently. TEST 
RESULTS
Responses were classified into four types (table III) according to whether a flush was reported when sherry was taken after chlorpropamide but not placebo, after both chlorpropamide and placebo, after placebo but not chlorpropamide, or not at all. According to the definition of Leslie and Pyke, only the first constitutes a true chlorpropamide alcohol flush. By these criteria the prevalence of a true chlorpropamide alcohol flush in our study (table III) was 620°0 among non-diabetics, 9 70' among patients with insulin dependent diabetes, and 10 20o among all patients with non-insulin dependent diabetes (10 50o among those not receiving chlorpropamide therapeutically). The differences between these groups were not significant (p >005). There was no significant difference in the prevalence of chlorpropamide alcohol flushing between subjects with and without a family history of diabetes in the group with non-insulin dependent diabetes (7 8°o and 11 90o respectively; p--0 05) or in either of the two other groups. The mean age, mean body mass index (weight/ height2), and sex ratio among subjects in each diagnostic group who showed a true chlorpropamide alcohol flush did not differ significantly from those among the rest of the group (table IV) .
A flush after both chlorpropamide and placebo occurred in 56-3% of patients with non-insulin dependent diabetes taking chlorpropamide long term compared with 16 70/o of the rest of the group with non-insulin dependent diabetes, 6 9%o of the group with insulin dependent diabetes, and 5 9%/ of the non-diabetic subjects (table III) . The difference in prevalence between the patients taking chlorpropamide long term and each of the other groups was highly significant (p<0 01); the prevalence among non-insulin dependent diabetics not taking chlorpropamide was also significantly different from that among the non-diabetics and among the insulin dependent diabetics (p<0 05). Further analyses of the group with non-insulin dependent diabetes did not bring to light any association between flushing after both chlorpropamide and placebo and any other chronic antidiabetic treatment besides chlorpropamide. This response occurred in nine (10 8%/) of the 84 patients taking diet alone or with metformin; 16 (16 7%/) of the 96 taking glibenclamide alone or with metformin; nine (19 1%0) of the 47 taking insulin; and one (1000%) of the 12 taking other antidiabetic drugs. There was a slight but significant (p<0 05) excess of women with non-insulin dependent diabetes compared with men who flushed after both chlorpropamide and placebo (29/122 women (238%/') v 13/120 men (11 1%/)); this difference was found in the age groups 40-59 and 60-79.
Discussion
Our study, using the single challenge test, shows no evidence of a significantly higher prevalence of flushing after chlorpropamide but not placebo in patients with non-insulin dependent diabetes compared with patients with insulin dependent diabetes and non-diabetic subjects. The response was unrelated to age, sex, body mass index, or family history of diabetes in any of the three groups. The prevalence of chlorpropamide alcohol flushing (105°,)) in patients with non-insulin dependent diabetes, excluding those taking chlorpropamide long term, was much lower than the 51% reported by Leslie and Pyke.6 The patients taking chlorpropamide long term, however, differed from the rest of the group with non-insulin dependent diabetes and the patients with insulin dependent diabetes and the non-diabetics by having a significantly higher prevalence of flushing after both chlorpropamide and placebo (56 3°'). Because of the long term treatment with chlorpropamide they would have had therapeutic plasma concentrations of the drug whether they took a preparatory chlorpropamide or placebo tablet for the test and would therefore, if susceptible to chlorpropamide alcohol flushing, flush with alcohol after both preparations instead of only after chlorpropamide. Chronic chlorpropamide treatment thus invalidates the placebo control and increases the prevalence of chlorpropamide alcohol flushing.
Most of Leslie and Pyke's patients with non-insulin diabetes were receiving chlorpropamide therapeutically,6 14 who found significantly higher concentrations in patients who showed chlorpropamide alcohol flushing than in non-responders (68-4 (SEM 9-3) and 25-2 (2-1) mg/l respectively), and by our own studies19 showing conversion of negative responses to positive by prolonged administration of chlorpropamide. Seven out of 10 patients with insulin dependent and eight out of 10 with non-insulin dependent diabetes who did not respond to the single dose test did so after receiving chlorpropamide for seven days, which resulted in a threefold increase in plasma concentration. Similar findings were reported by Pontiroli et al,20 who showed that positive responses were eight to 10 times higher in diabetics who received four doses of 250 mg chlorpropamide than in those who received only a single dose.
Probably, too, the intensity of the flush is related to plasma chlorpropamide concentration. Responses after a single dose of the drug may be equivocal or mild, unreproducible, or correlate imperfectly with the rise in facial temperature.16 21 22 Presumably subjects who flush after a single dose represent individuals particularly susceptible to the flush-producing potential of the drug. The flush response depends on enzymes of alcohol and acetaldehyde metabolism 3 24; SO it would not be surprising if it, like enzyme activity, were inherited, whether related to noninsulin dependent diabetes or not.
We conclude that there is no evidence of a specific association between the chlorpropamide alcohol flush, as determined by the single challenge test, and non-insulin dependent diabetes, high prevalences having been reported as an effect of prolonged chlorpropamide treatment in non-insulin dependent diabetics. These observations must strongly undermine the assertion that the chlorpropamide alcohol flush is a marker for non-insulin dependent diabetes with a familial occurrence.
SHORT REPORTS
Heberden's nodes in osteoarthritis and rheumatoid arthritis
William Heberden was the first to describe the firm swellings of the distal interphalangeal joints that are now regarded as characteristic of generalised osteoarthritis.1 Rheumatoid arthritis causes soft swellings around metacarpophalangeal and proximal interphalangeal joints but is usually thought to spare the distal interphalangeal joints.2 Clinical abnormalities of the distal interphalangeal joints in patients with rheumatoid arthritis have been noted, however,3 4 and generalised osteoarthritis and rheumatoid arthritis may coexist more often than would be expected by chance,5 but no controlled data are available. We made a comparative study of clinical and radiological changes in the distal interphalangeal joints in rheumatoid arthritis and generalised osteoarthritis.
Patients, methods, and results
One hundred consecutive outpatients attending a rheumatology clinic with classical or definitive rheumatoid arthritis (American Rheumatism Association criteria) were compared with 40 patients with generalised osteoarthritis and 42 controls matched for age and sex admitted to hospital for non-rheumatic disorders. Their hands were examined by the same observer, and individual distal interphalangeal and proximal interphalangeal joints were given scores from 0 to 3 (0=normal, 1-firm swelling, 2=soft swelling, 3=swollen, hot, and tender). Age, sex, duration of disease, and presence of rheumatoid factor were also noted. Anterior-posterior hand radiographs were examined by a radiologist who was unaware of the clinical findings; seven different features were scored as present or absent (table) The mean age of the group with rheumatoid arthritis was 57-7 (SD 12-3); mean duration of symptoms was 9 7 years. Eighty one patients were positive for rheumatoid factor on latex agglutination testing, and the ratio of men to women was 1:2-5. The mean age of the group with generalised osteoarthritis was 65-8 (10-2) and mean duration of symptoms 7-8 years; none was seropositive, and the ratio of men to women was 1:4-7. The control group was well matched with the group with rheumatoid arthritis (mean age 59-1 (12-9), M:F= 1:2 5).
Clinical abnormalities of the distal interphalangeal joints were seen in 67 (67%' ) of the patients with rheumatoid arthritis compared with 33 (92%) of the patients with generalised osteoarthritis and 17 (41%) of the controls (group with rheumatoid arthritis versus controls: x2= 15-2, p< 0-01).
Grade 2 or 3 changes were seen in 12 (12%), nine (24%), and two (5%) patients respectively. The changes in the group with rheumatoid arthritis were often clinically indistinguishable from those in the group with osteoarthritis. The table summarises the radiological findings.
The soft tissue swelling of the distal interphalangeal joints was common in both osteoarthritis and rheumatoid arthritis, but not in the control group. Juxta-articular osteoporosis and ill defined erosions were present in the distal phalangeal joints in 33 and 12 patients respectively with rheumatoid arthritis but were not seen in patients with osteoarthritis or in controls. Subchondral cysts were also commoner in the groups with osteoarthritis and rheumatoid arthritis than in the control group (p<0-01). Osteophytes, ossicles, and narrowing of the joint space were common in all three groups of patients.
Comment
This study confirms previous reports suggesting that the distal interphalangeal joints are often affected in rheumatoid arthritis.3 ' The changes were often clinically indistinguishable from Heberden's nodes and occurred more commonly in these patients than in the control population. Radiological changes included typical features of rheumatoid arthritis such as juxta-articular osteoporosis (33%) and ill defined erosions (12%' ). Of the 12 patients with rheumatoid erosions of the distal interphalangeal joints, 10 were strongly seropositive and all had typical rheumatoid changes at other joint sites. 
